Moby

Premium HEALTHCARE

Novo Plunges After “Lottery Ticket” Alzheimer’s GLP-1 Study Fails

13 days ago

Premium HEALTHCARE

Zepbound to the Moon: Eli Lilly Joins the Trillionaire Club

16 days ago

Novo’s Slim-Down Strategy Taps Cheaper Wegovy To Keep It On Top

19 days ago

Switzerland Nears Trump Tariff Truce at 15%

26 days ago

Novo’s India Play: A Second Name For The Same Shot

27 days ago

Trump Is Making Skinny Drugs Cheaper

30 days ago

Lilly Expands In Novo Territory with $3 Billion Drug Plant in Netherlands

More than a month ago

Premium CONSUMER

Kimberly-Clark to Buy Tylenol’s Chaos for $48.7 Billion

More than a month ago

Ireland’s GDP Trips Over Tariff Drama

More than a month ago

Premium HEALTH CARE

Cigna Finally Notices Everyone Hates Drug Prices

More than a month ago

Premium FASHION

Kering’s Beauty Exit Blushes L’Oréal

More than a month ago

Premium CANNABIS

Cannabis Giant Tilray Up Nearly 30% As It Posts Profitable Quarter

More than a month ago

Premium HEALTH CARE

Amazon & One Medical May Have a Cure for America’s Coming Premium Shock

More than a month ago

Merck Begins Next Act As Chip Guy Takes the Helm

2 months ago

Premium PHARMACEUTICALS

Trump White House Strikes “Discount” Deal With Pfizer

2 months ago

AstraZeneca Takes Wall Street Detour While Keeping London Address

2 months ago

Trump’s Pharma Tariffs Leave Europe With a Headache

2 months ago

Tylenol Survives Trump as Science Prevails

2 months ago

Pfizer Finally Buys Its Way Into Ozempicland

2 months ago

Novo’s Wegovy Pill Lands A Heavyweight Punch

3 months ago

Premium VACCINES

Pfizer, Moderna Crater as Trump Officials Link Covid to Child Deaths

3 months ago

Novo Nordisk Sheds Some Weight, Cuts 9,000 Jobs

3 months ago

Premium HEALTHCARE

Convatec’s $300M Buyback Puts the Bandages on Investor Wounds

4 months ago

Novo Nordisk Stock Swells as It Slashes Ozempic Prices

4 months ago